PUREVAX Ferret Distemper

Distemper Vaccine

Live Canarypox Vector

Description

PUREVAX^® Ferret Distemper is a lyophilized vaccine of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible ferrets.

PUREVAX Ferret Distemper Indications

PUREVAX^® Ferret Distemper is recommended for the vaccination of healthy ferrets 8 weeks of age and older for prevention of disease due to canine distemper virus.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy ferrets 8 weeks of age and older. Primary vaccination requires two additional 1 mL doses at 3 week intervals. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. It is generally recommended to avoid vaccination of pregnant ferrets. Administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Transient lethargy, as well as pain and swelling at the site of injection, may occur following use of this product. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by veterinarian.

For Veterinary Use Only.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed in Canada By: MERIAL CANADA, INC., Baie d'Urfé, Qc, H9X 4B6

PUREVAX is a registered trademark of MERIAL.

NAC No.: 11110833